awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28076777-5A9B1A45-580B-464E-8AEA-302E7816BEF3
Q28076777-5A9B1A45-580B-464E-8AEA-302E7816BEF3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28076777-5A9B1A45-580B-464E-8AEA-302E7816BEF3
Review of hormone-based treatments in postmenopausal patients with advanced breast cancer focusing on aromatase inhibitors and fulvestrant
P2860
Q28076777-5A9B1A45-580B-464E-8AEA-302E7816BEF3
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28076777-5A9B1A45-580B-464E-8AEA-302E7816BEF3
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
8d840246a81169649715f179c7fb5bc758cc8c00
P2860
Results of the CONFIRM phase III trial comparing fulvestrant 250 mg with fulvestrant 500 mg in postmenopausal women with estrogen receptor-positive advanced breast cancer.